Efficacy of topical tofacitinib, a Janus kinase inhibitor, in the treatment of plaque psoriasis

被引：6
|
作者：
Bagherani, Nooshin [1 ]
Smoller, Bruce R. [2 ]
机构：
[1] Dr Nooshin Bagherans Off, Khoramshahr, Khuzestan Provi, Iran
[2] Univ Rochester, Sch Med & Dent, Dept Dermatol, Dept Pathol, Rochester, NY 14642 USA
来源：
DERMATOLOGIC THERAPY | 2017年 / 30卷 / 03期
关键词：
psoriasis; tofacitinib; treatment; CLINICAL-TRIAL;
D O I：
10.1111/dth.12467
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] INTEGRATED EFFICACY ANALYSIS OF TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Nash, P.
    Coates, L. C.
    Fleischmann, R.
    Papp, K. A.
    Gomez-Reino, J. J.
    Kanik, K. S.
    Wang, C.
    Wu, J.
    Hendrikx, T.
    Ports, W. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 951 - 952
  • [32] New topical treatment for plaque psoriasis
    不详
    NURSE PRACTITIONER, 2019, 44 (08): : 56 - 56
  • [33] Topical Therapies for the Treatment of Plaque Psoriasis
    Bagel, Jerry
    CUTIS, 2009, 84 (04): : 3 - 13
  • [34] Janus Kinase Inhibitor Tofacitinib for Induction and Remission in ulcerative colitis
    Sandborn, W. J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (14) : 1022 - 1023
  • [35] Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
    Sandborn, William J.
    Ghosh, Subrata
    Panes, Julian
    Vranic, Ivana
    Su, Chinyu
    Rousell, Samantha
    Niezychowski, Wojciech
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (07): : 616 - 624
  • [36] Tofacitinib: A novel oral Janus kinase inhibitor for rheumatoid arthritis
    O'Dell, Kate M.
    Rummel, Ashley E.
    FORMULARY, 2012, 47 (10) : 350 - +
  • [37] Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
    Wollenhaupt, Juergen
    Silverfield, Joel
    Lee, Eun Bong
    Curtis, Jeffrey R.
    Wood, Susan P.
    Soma, Koshika
    Nduaka, Chudy I.
    Benda, Birgitta
    Gruben, David
    Nakamura, Hiroyuki
    Komuro, Yoshihiro
    Zwillich, Samuel H.
    Wang, Lisy
    Riese, Richard J.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (05) : 837 - 852
  • [38] Tofacitinib and Other Kinase Inhibitors in the Treatment of Psoriasis
    Ortiz-Ibanez, K.
    Alsina, M. M.
    Munoz-Santos, C.
    ACTAS DERMO-SIFILIOGRAFICAS, 2013, 104 (04): : 304 - 310
  • [39] Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population
    Hall, Stephen
    Nash, Peter
    Rischmueller, Maureen
    Bossingham, David
    Bird, Paul
    Cook, Nicola
    Witcombe, David
    Soma, Koshika
    Kwok, Kenneth
    Thirunavukkarasu, Krishan
    RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 383 - 401
  • [40] Efficacy and safety of topical INCB018424, a selective Janus kinase 1 & 2 (JAK1&2) inhibitor in psoriasis
    Punwani, Naresh
    Gottlieb, Alice
    Birnbaum, Jay
    Williarns, William
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB176 - AB176
12345